Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week

Torsten Doenst1, Robert O Bonow2, Deepak L Bhatt3

  • 1Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller-University of Jena, Jena, Germany.

Insights

The term "myocardial revascularization" for coronary artery disease (CAD) treatments like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) is misleading. A descriptive term, "invasive treatment," better reflects the complex benefits of PCI and CABG.

Area of Science:

  • Cardiology
  • Medical Terminology
  • Clinical Practice

Background:

  • Coronary artery disease (CAD) management includes medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG).
  • PCI and CABG are often grouped under the term "myocardial revascularization."
  • This umbrella term may oversimplify the distinct physiological effects of these invasive procedures.

Purpose of the Study:

  • To critically evaluate the appropriateness of the term "myocardial revascularization" for PCI and CABG.
  • To propose an alternative, more descriptive terminology for invasive CAD treatments.
  • To enhance clinical decision-making and guide future research in cardiovascular interventions.

Main Methods:

  • Review of current evidence on the mechanisms and effects of PCI and CABG.
  • Analysis of the implications of terminology on understanding treatment outcomes.
  • Comparative assessment of "myocardial revascularization" versus descriptive terms.

Main Results:

  • The term "myocardial revascularization" inaccurately suggests a singular effect (restoring blood flow to ischemic tissue).
  • It obscures crucial mechanisms like improved coronary flow without ischemia, reperfusion during ischemia, and prevention of myocardial infarction.
  • PCI and CABG encompass a broader range of therapeutic benefits than implied by "myocardial revascularization."

Conclusions:

  • The term "myocardial revascularization" is inappropriate for describing PCI and CABG.
  • A purely descriptive terminology, such as "invasive treatment by PCI or CABG," is recommended.
  • Adopting precise terminology can improve clinical decision-making and inform future trial designs for CAD interventions.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...